DYRK2 and cancer: MiR-622: MiR-622 is downregulated in CRC and suppresses migration, invasion, and proliferation of cancer cells by targeting various targets such as dual-specificity tyrosine phosphorylation-regulated kinase 2 (DYRK2) and Kirsten rat sarcoma (K-Ras) [201].